(2004; 45 pages)
Writing new material for the national formulary
Once information has been collected and summarized for the purpose of insertion into the NF (see Chapter 5), it is crucial that development of the draft text follows a rigorous process including:
• Writing the draft text in a clear, accurate style that is tailored to the purpose of the NF with sufficient detail in both introductory texts and in the monographs. The writing style used for additional text in the NF should be in harmony with the adapted WMF writing style.
• Structuring the draft text to make the information easily accessible. Subheadings should follow existing structures. If the additional medicine will be used for different conditions, the relevant cross-references should be carefully included and monographs should reflect all recommended indications, dosage schedules, warnings, etc. for the different uses.
• Reviewing the draft text at several levels:
• peer-review by members of the editorial team;
• content review by members of the advisory group to check readability and relevance to the intended audience; and
• technical copy-editing and proofreading to check accuracy and validity, as already described.
• Formatting the draft text using a clearly distinguishable style that indicates additions to WMF text as discussed earlier.
• Positioning of the draft text within the adapted text of the WMF. When inserting additional text in the introductory section, try to maintain the clarity of the WMF text while giving the necessary prominence to the additional local information. New monographs should be placed within the relevant therapeutic/pharmacological section. In the case of multiple indications, a decision needs to be made on where to place the main monograph and how to provide clear cross-references in other chapters where the medicine is mentioned.
• Creating additional information to be included in specific sections such as that on drug interactions, other appendices, table of contents and indexing field codes.